Murata Manufacturing Stock Leads 3 Japanese Picks Backed By Strong Cash Flow

With inflation, interest rate expectations and energy prices all pulling markets in different directions, cash flow has become a key anchor for many investors. When a stock generates solid cash flows yet trades below an independently assessed fair value, it can offer a way to stay disciplined while others react to headlines. The Undervalued Stocks Based On Cash Flows screener focuses on companies where SWS DCF valuation suggests a gap between price and underlying cash potential. In this article, you will see 3 of the most interesting stocks from this list that may merit a closer look.

Chugai Pharmaceutical (TSE:4519)

Overview: Chugai Pharmaceutical is a Japan based drug company focused on high value therapies in oncology, autoimmune and rare diseases, built around biologic and monoclonal antibody treatments, and supported by its long running relationship with Roche for research, manufacturing and global distribution.

Operations: Chugai generates all of its ¥1,291.2b revenue from pharmaceuticals, with reported sales primarily across Japan and Switzerland.

Market Cap: ¥12,023.9b

Chugai Pharmaceutical may appeal to investors who care about both cash generation and medical impact, with a portfolio of biologic drugs such as Hemlibra and Actemra, high net margins around 35% and a P/E that is below the level implied by the Simply Wall St DCF estimate. At the same time, the stock depends heavily on a handful of flagship products and on its partnership with Roche, while operating in a sector facing regulatory and pricing pressure. Earnings growth forecasts above 10% per year and a return on equity above 20% are reported alongside those risks, and the relationship between Chugai’s current price, its analyst targets and SWS fair value may be of interest to investors who are prepared to scrutinize the assumptions behind them.

Chugai Pharmaceutical’s strong cash generation and reported high margins set a clear story, but the valuation gap is where it gets interesting. Tap into the DCF valuation analysis for Chugai Pharmaceutical and see what might be hiding behind the headline numbers.

Furukawa Electric (TSE:5801)

Overview: Furukawa Electric is a Japan based industrial group that supplies optical fiber, power cables, automotive wire harnesses and metal products that underpin telecom networks, energy grids and vehicle electrification around the world.

Operations: Furukawa Electric generates most of its ¥1,341.6b revenue from Electrical Electronics at ¥765.1b and Infrastructure at ¥370.9b, with smaller contributions from Functional Products at ¥161.1b and Services and Developments at ¥42.2b.

Market Cap: ¥2,479.8b

Furukawa Electric sits at the intersection of several long term themes, from fiber networks to high voltage wiring for electric and hybrid vehicles. Earnings grew very strongly over the past year and are forecast to rise further alongside double digit revenue growth expectations. At the same time, the stock carries clear tension points, including a P/E that is well above the broader electrical industry and debt that is not well covered by operating cash flow, all against a backdrop of recent one off items in the accounts. The share price currently sits below one DCF based fair value estimate and analyst targets imply further upside. The key consideration for investors is how to weigh those growth signals against the funding and volatility risks.

Furukawa Electric’s earnings and revenue forecasts are rising while the stock sits below one DCF based fair value estimate, which raises a simple question for investors: is the market underestimating the next phase or already pricing in the catch? Compare those expectations, risks and valuation signals in the analyst forecasts for Furukawa Electric

Murata Manufacturing (TSE:6981)

Overview: Murata Manufacturing is a Japan based electronics company that supplies ceramic capacitors, inductors, sensors, batteries and connectivity modules that sit inside smartphones, cars, data centers, industrial equipment and a wide range of connected devices.

Operations: Murata Manufacturing generates most of its ¥1,933.9b revenue from Components at ¥1,175.2b and Devices and Modules at ¥656.0b, with a small contribution from Others at ¥69.7b.

Market Cap: ¥15,139.4b

Murata Manufacturing catches the eye because its shares are reported to trade more than 20% below one fair value estimate. Analysts also expect earnings to grow about 24.3% a year and revenue to rise 12.6% a year, ahead of the wider Japanese market. The company is pushing into growth areas such as automotive grade capacitors and ultra low power sensors, while also committing to higher dividends and a sizeable buyback of up to ¥150.0b, which could support per share metrics. Set against that, investors need to weigh a high P/E, a history of earnings decline over 5 years, volatile trading and concerns around debt funding and board turnover. These factors make a deeper look particularly important.

Murata Manufacturing’s reported valuation gap, earnings rebound and push into automotive and low power components point to a story that feels incomplete, so walk through the analyst forecasts for Murata Manufacturing before assuming the risks outweigh the upside

The three stocks in this article are only a starting point. The full Undervalued Stocks Based On Cash Flows Undervalued Stocks Based On Cash Flows screener surfaces 56 more companies where discounted cash flow suggests a similar disconnect between price and cash potential. Use Simply Wall St to identify and analyze the specific catalysts, cash flow trends and valuation narratives that matter most to you so you can focus on the highest conviction opportunities.

Take Control of Your Investment Journey

If Furukawa Electric or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Before Momentum Flies?

Some of the sharpest breakouts start quietly, then move fast once the crowd catches on. Before these ideas stop looking under the radar for now, consider researching them early.

• Spot cash rich companies quietly gathering momentum before headlines catch up by running the list of solid balance sheet and fundamentals (37 results), which is built to surface businesses with sturdier finances and cleaner fundamentals.
• Explore potential structural shifts in global power systems by scanning the 35 power grid technology and infrastructure stocks and filtering for companies tied to grid upgrades that others might still be overlooking.
• Focus on companies building the AI backbone with the 54 AI infrastructure stocks, so you are tracking businesses tied to data centers, chips and networking while it is particularly relevant.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com